Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich to Acquire Nucleic Acid Manufacturer Proligo

NEW YORK, Feb. 16 (GenomeWeb News) - Sigma-Aldrich plans to purchase DNA and RNA maker Proligo from Degussa, the company said today.


Financial and other terms of the proposed acquisition were not disclosed.


Proligo, headquartered in Boulder, Colo., provides custom DNA, RNA, and raw materials for DNA and RNA synthesis. The company is one of four exclusive licensees to an RNAi patent application owned by MIT.


Last year, Proligo had approximately $40 million in sales. The company has manufacturing sites in Boulder, France, Germany, Singapore, Japan, and Australia, and has about 300 employees.


"We expect this investment to permit us to participate as a global leader in the genomics and gene-silencing research tools markets for years to come," said David Harvey, Sigma's CEO, in a statement.


The acquisition, which Sigma plans to fund with short-term debt, has already been cleared with both companies' boards of directors. Subject to regulatory approval in Germanyand other terms and conditions, the deal is expected to close early in the second quarter of this year.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.